ibandronic acid has been researched along with Pain in 33 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (6.06) | 18.2507 |
| 2000's | 20 (60.61) | 29.6817 |
| 2010's | 10 (30.30) | 24.3611 |
| 2020's | 1 (3.03) | 2.80 |
| Authors | Studies |
|---|---|
| Fehr, T; Jeker, R; Küchler, L | 1 |
| Aleksandrova, EN; Alekseeva, LI; Demin, NV; Sharapova, EP; Smirnov, AV; Taskina, EA; Zaitseva, EM | 1 |
| Bray, C; Canney, P; Hannon, RA; Hopkins, C; Lewsley, LA; Macpherson, IR; Ritchie, DM | 1 |
| Bloomfield, D; Forsyth, S; Hackshaw, A; Hoskin, P; Jitlal, M; Kirkwood, A; Mithal, N; Reczko, K; Sizer, B; Stratford, M; Sundar, S; Upadhyay, S; Wilson, P | 1 |
| Burian, E; Ehrenfeld, M; Mahaini, S; Otto, S; Pautke, C; Probst, F; Smolka, W; Troeltzsch, M | 1 |
| Bauss, F; Bergström, B | 1 |
| Pecherstorfer, M | 1 |
| Li, M; Liu, DG; Liu, JL; Meng, XW; Xia, WB; Xing, XP; Zhang, ZL | 1 |
| Bergner, R; Diel, IJ; Kurth, AH; Maasberg, M; Meden, H; Sandermann, A; Sittig, HB | 1 |
| Biti, G; Bruni, A; Cipressi, S; De Luca Cardillo, C; Galardi, A; Livi, L; Meattini, I; Scotti, V | 1 |
| Hatzopoulos, A; Heras, P; Heras, V; Karagiannis, S; Kritikos, K; Kritikos, N | 1 |
| Carranza-Lira, S; García-Hernández, P; Motta-Martínez, E | 1 |
| Altundag, K; Dizdar, O; Eralp, Y; Karahoca, M; Komurcu, S; Kuzhan, O; Ozguroglu, M; Ozkok, S; Ozsaran, Z; Saip, P | 1 |
| Elert, A; Heidenreich, A; Hofmann, R | 1 |
| Heidenreich, A | 1 |
| Apffelstaedt, J; Bergstrom, B; Budde, M; Lazarev, A; Lichinitzer, M; MacLachlan, SA; Tripathy, D | 1 |
| Bergström, B; Body, JJ; Budde, M; Diel, IJ; Dornoff, W; Gorbunova, VA; Kreuser, ED; Lichinitser, MR | 1 |
| Body, JJ; Dumon, JC; Mancini, I | 1 |
| Bell, R; Bergström, B; Body, JJ; Diel, IJ; Lazarev, AF; Lichinitser, MR; Pecherstorfer, M; Tripathy, D | 1 |
| Rexer, H | 1 |
| Body, JJ; Heidenreich, A; Ohlmann, C | 1 |
| Hoskin, PJ | 1 |
| Bergström, B; Body, JJ; Tripathy, D | 1 |
| Dorst, A; Faber, H; Ringe, JD | 1 |
| Faber, H; Farahmand, P; Ringe, JD | 1 |
| Cameron, D; Diel, I; Fallon, M | 1 |
| Christopoulos, C; Kalogeropoulou, C; Kardamakis, D; Leotsinides, M; Solomou, E; Vassiliou, V | 1 |
| Giannopoulou, E; Kalogeropoulou, C; Kardamakis, D; Leotsinidis, M; Tsota, I; Vassiliou, V | 1 |
| Clemons, M; Cole, DE; Dranitsaris, G; Ooi, W | 1 |
| Bauss, F; Ghilardi, JR; Halvorson, KG; Koewler, NJ; Mantyh, PW; Sevcik, MA; Sullivan, LJ | 1 |
| Coleman, R; Vinholes, J | 1 |
| Bartl, R; Body, JJ; Burckhardt, P; Delmas, PD; Diel, IJ; Fleisch, H; Kanis, JA; Kyle, RA; Mundy, GR; Paterson, AH; Rubens, RD | 1 |
| Boewer, C; Delmas, PD; Euller-Ziegler, L; Facon, T; Fiere, D; Fontana, A; Herrmann, Z; Hrubisko, M; Lichinitser, MR; Menssen, HD; Sakalová, A; Singer, CR; Thiel, E; Wetterwald, M | 1 |
7 review(s) available for ibandronic acid and Pain
| Article | Year |
|---|---|
Preclinical and clinical efficacy of the bisphosphonate ibandronate in cancer treatment.
Topics: Animals; Bone Density Conservation Agents; Bone Neoplasms; Diphosphonates; Humans; Ibandronic Acid; Osteoporosis; Pain | 2008 |
Oral ibandronate in metastatic bone breast cancer: the Florence University experience and a review of the literature.
Topics: Administration, Oral; Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Diphosphonates; Humans; Ibandronic Acid; Pain; Quality of Life | 2010 |
Bisphosphonates in the management of metastatic prostate cancer.
Topics: Antineoplastic Agents; Bone Neoplasms; Chemotherapy, Adjuvant; Diphosphonates; Humans; Ibandronic Acid; Imidazoles; Male; Pain; Palliative Care; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Treatment Outcome; Zoledronic Acid | 2003 |
Ibandronate in metastatic bone pain.
Topics: Administration, Oral; Bone Neoplasms; Breast Neoplasms; Clinical Trials as Topic; Diphosphonates; Humans; Ibandronic Acid; Infusions, Intravenous; Pain; Urologic Neoplasms | 2004 |
Review of ibandronate in the treatment of metastatic bone disease: experience from phase III trials.
Topics: Administration, Oral; Bone Neoplasms; Breast Neoplasms; Clinical Trials, Phase III as Topic; Diphosphonates; Humans; Ibandronic Acid; Infusions, Intravenous; Multicenter Studies as Topic; Pain; Poisson Distribution; Randomized Controlled Trials as Topic | 2004 |
Ibandronate: its role in metastatic breast cancer.
Topics: Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Clinical Trials, Phase III as Topic; Diphosphonates; Dose-Response Relationship, Drug; Female; Humans; Ibandronic Acid; Pain; Randomized Controlled Trials as Topic | 2006 |
Current use of bisphosphonates in oncology. International Bone and Cancer Study Group.
Topics: Analgesics, Non-Narcotic; Bone and Bones; Bone Neoplasms; Bone Resorption; Breast Neoplasms; Clodronic Acid; Diphosphonates; Humans; Hypercalcemia; Ibandronic Acid; Multiple Myeloma; Pain; Pamidronate | 1998 |
11 trial(s) available for ibandronic acid and Pain
| Article | Year |
|---|---|
Loading dose ibandronate versus standard oral ibandronate in patients with bone metastases from breast cancer.
Topics: Administration, Oral; Aged; Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Collagen Type I; Diphosphonates; Female; Humans; Ibandronic Acid; Infusions, Intravenous; Middle Aged; Pain; Peptides | 2015 |
A Multicenter Randomized Trial of Ibandronate Compared With Single-Dose Radiotherapy for Localized Metastatic Bone Pain in Prostate Cancer.
Topics: Aged; Aged, 80 and over; Bone Density Conservation Agents; Bone Neoplasms; Diphosphonates; Humans; Ibandronic Acid; Infusions, Intravenous; Male; Middle Aged; Pain; Palliative Care; Prostatic Neoplasms; Quality of Life; Radiotherapy Dosage; Time Factors; Treatment Outcome | 2015 |
Infusion of ibandronate once every 3 months effectively decreases bone resorption markers and increases bone mineral density in Chinese postmenopausal osteoporotic women: a 1-year study.
Topics: Aged; Alkaline Phosphatase; Biomarkers; Body Height; Bone Density; Bone Density Conservation Agents; Bone Resorption; China; Collagen Type I; Diphosphonates; Female; Femur; Femur Neck; Humans; Ibandronic Acid; Infusions, Intravenous; Lumbar Vertebrae; Middle Aged; Muscular Diseases; Osteoporosis, Postmenopausal; Pain; Peptides; Time Factors | 2010 |
A comparative study of intravenous ibandronate and pamindronate in patients with bone metastases from breast or lung cancer: effect on metastatic bone pain.
Topics: Bone Density Conservation Agents; Bone Neoplasms; Bone Resorption; Breast Neoplasms; Diphosphonates; Female; Humans; Ibandronic Acid; Lung Neoplasms; Male; Middle Aged; Pain; Pamidronate; Quality of Life | 2011 |
[Monthly ibandronate attachment to Mexican and Chilean women with osteoporosis, with or without a biofeedback strategy].
Topics: Administration, Oral; Aged; Biofeedback, Psychology; Biomarkers; Bone Density Conservation Agents; Calcium; Chile; Collagen Type I; Diphosphonates; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Ibandronic Acid; Mexico; Middle Aged; Osteoporosis, Postmenopausal; Pain; Patient Compliance; Patient Satisfaction; Peptides; Prospective Studies; Vitamin D | 2010 |
Phase II study of loading-dose ibandronate treatment in patients with breast cancer and bone metastases suffering from moderate to severe pain.
Topics: Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Diphosphonates; Female; Humans; Ibandronic Acid; Infusions, Intravenous; Injections, Intravenous; Middle Aged; Pain; Pain Measurement; Prospective Studies; Treatment Outcome | 2012 |
Oral ibandronate for the treatment of metastatic bone disease in breast cancer: efficacy and safety results from a randomized, double-blind, placebo-controlled trial.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Analgesics; Bone Neoplasms; Breast Neoplasms; Diphosphonates; Double-Blind Method; Drug Administration Schedule; Female; Humans; Ibandronic Acid; Middle Aged; Morbidity; Pain; Placebos | 2004 |
Improved quality of life after long-term treatment with the bisphosphonate ibandronate in patients with metastatic bone disease due to breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Analgesics; Bone Neoplasms; Breast Neoplasms; Diphosphonates; Double-Blind Method; Female; Humans; Ibandronic Acid; Infusions, Intravenous; Long-Term Care; Middle Aged; Pain; Quality of Life; Survival Analysis; Treatment Outcome | 2004 |
Oral ibandronate improves bone pain and preserves quality of life in patients with skeletal metastases due to breast cancer.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Breast Neoplasms; Diphosphonates; Double-Blind Method; Female; Humans; Ibandronic Acid; Middle Aged; Pain; Quality of Life; Statistics, Nonparametric | 2004 |
A Phase II trial evaluating the palliative benefit of second-line oral ibandronate in breast cancer patients with either a skeletal related event (SRE) or progressive bone metastases (BM) despite standard bisphosphonate (BP) therapy.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Bone and Bones; Bone Density Conservation Agents; Bone Diseases; Bone Neoplasms; Breast Neoplasms; Diphosphonates; Female; Humans; Ibandronic Acid; Infusions, Intravenous; Middle Aged; Pain; Palliative Care; Pamidronate | 2008 |
Effects of long-term intravenous ibandronate therapy on skeletal-related events, survival, and bone resorption markers in patients with advanced multiple myeloma.
Topics: Bone Resorption; Chi-Square Distribution; Diphosphonates; Double-Blind Method; Female; Fractures, Bone; Humans; Hypercalcemia; Ibandronic Acid; Injections, Intravenous; Male; Middle Aged; Multiple Myeloma; Pain; Spinal Cord Compression; Survival Analysis; Treatment Outcome | 2002 |
15 other study(ies) available for ibandronic acid and Pain
| Article | Year |
|---|---|
Pain control with ibandronate for bone marrow oedema of the knee.
Topics: Bone Marrow; Bone Marrow Diseases; Diphosphonates; Edema; Humans; Ibandronic Acid; Magnetic Resonance Imaging; Pain; Prospective Studies; Retrospective Studies | 2020 |
[Evaluation of the efficacy and tolerance of ibandronic acid in patients with osteoarthrosis in the knee joints concurrent with osteoporosis: a pilot study].
Topics: Aged; Bone Density Conservation Agents; Bone Resorption; Cartilage; Diphosphonates; Disability Evaluation; Female; Humans; Ibandronic Acid; Locomotion; Middle Aged; Osteoarthritis, Knee; Osteoporosis, Postmenopausal; Pain; Pain Measurement; Pilot Projects; Severity of Illness Index | 2013 |
Ibandronate treatment of diffuse sclerosing osteomyelitis of the mandible: Pain relief and insight into pathogenesis.
Topics: Adolescent; Adult; Aged; Bone Density Conservation Agents; Diphosphonates; Female; Humans; Ibandronic Acid; Infusions, Intravenous; Male; Mandibular Diseases; Middle Aged; Osteomyelitis; Pain; Recurrence; Retrospective Studies; Visual Analog Scale; Young Adult | 2015 |
Managing neoplastic bone disease with ibandronic acid: a preclinical and clinical data update.
Topics: Animals; Antineoplastic Agents; Bone Neoplasms; Clinical Trials as Topic; Diphosphonates; Drug Evaluation, Preclinical; Drug Tolerance; Humans; Ibandronic Acid; Pain | 2008 |
Bone pain reduction in patients with metastatic breast cancer treated with ibandronate-results from a post-marketing surveillance study.
Topics: Administration, Oral; Aged; Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Creatinine; Diphosphonates; Female; Humans; Ibandronic Acid; Infusions, Intravenous; Middle Aged; Pain; Prospective Studies; Severity of Illness Index | 2010 |
Ibandronate in the treatment of prostate cancer associated painful osseous metastases.
Topics: Aged; Bone Neoplasms; Diphosphonates; Humans; Ibandronic Acid; Male; Middle Aged; Pain; Prospective Studies; Prostatic Neoplasms | 2002 |
Efficacy and safety of ibandronate in the treatment of opioid-resistant bone pain associated with metastatic bone disease: a pilot study.
Topics: Adult; Aged; Bone Neoplasms; Diphosphonates; Drug Resistance; Female; Humans; Ibandronic Acid; Injections, Intravenous; Male; Middle Aged; Narcotics; Pain; Pilot Projects; Quality of Life | 2004 |
[Therapy of painful bone metastases in patients with prostate carcinoma. The AP 32/02 Study of the AUO].
Topics: Antineoplastic Agents; Bone Neoplasms; Diphosphonates; Humans; Ibandronic Acid; Male; Mitoxantrone; Pain; Patient Selection; Prednisolone; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Research Design; Treatment Outcome | 2004 |
The RIB trial.
Topics: Biomarkers; Bone Neoplasms; Bone Resorption; Clinical Trials as Topic; Diphosphonates; Humans; Ibandronic Acid; Pain | 2004 |
Effective and rapid treatment of painful localized transient osteoporosis (bone marrow edema) with intravenous ibandronate.
Topics: Adult; Bone Density; Bone Density Conservation Agents; Bone Marrow; Bone Resorption; Calcium, Dietary; Dietary Supplements; Diphosphonates; Edema; Female; Humans; Ibandronic Acid; Injections, Intravenous; Lumbar Vertebrae; Male; Middle Aged; Osteoporosis; Pain; Pain Measurement; Quality of Life; Syndrome; Treatment Outcome; Vitamin D | 2005 |
Rapid pain relief and remission of sternocostoclavicular hyperostosis after intravenous ibandronate therapy.
Topics: Adult; Aged; Diphosphonates; Female; Humans; Hyperostosis, Sternocostoclavicular; Ibandronic Acid; Injections, Intravenous; Middle Aged; Pain; Radiography; Radionuclide Imaging; Radiopharmaceuticals; Sternoclavicular Joint; Technetium | 2006 |
Combination ibandronate and radiotherapy for the treatment of bone metastases: clinical evaluation and radiologic assessment.
Topics: Aged; Analgesics, Opioid; Bone Density Conservation Agents; Bone Diseases; Bone Neoplasms; Combined Modality Therapy; Diphosphonates; Female; Humans; Ibandronic Acid; Infusions, Intravenous; Magnetic Resonance Imaging; Male; Middle Aged; Pain; Pain Measurement; Pilot Projects; Prospective Studies; Statistics, Nonparametric | 2007 |
A novel study investigating the therapeutic outcome of patients with lytic, mixed and sclerotic bone metastases treated with combined radiotherapy and ibandronate.
Topics: Adult; Aged; Analgesics, Opioid; Bone Density; Bone Neoplasms; Combined Modality Therapy; Diphosphonates; Female; Humans; Ibandronic Acid; Male; Middle Aged; Pain; Quality of Life | 2007 |
Intravenous ibandronate rapidly reduces pain, neurochemical indices of central sensitization, tumor burden, and skeletal destruction in a mouse model of bone cancer.
Topics: Animals; Biomarkers, Tumor; Bone Density Conservation Agents; Bone Neoplasms; Cell Line, Tumor; Diphosphonates; Disease Models, Animal; Ibandronic Acid; Injections, Intravenous; Male; Mice; Mice, Inbred C3H; Osteolysis; Osteosarcoma; Pain; Pain Measurement; Treatment Outcome | 2008 |
The management of bone metastases.
Topics: Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Combined Modality Therapy; Diphosphonates; Female; Humans; Hypercalcemia; Ibandronic Acid; Middle Aged; Pain | 1995 |